SCHEMBL9529231

SCHEMBL9529231

CCC#Cc1nc(C(CC)(OC)OC)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 3/20 0.33
AGTR2 P50052 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9528274 0.93 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9528107 0.92 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL9698261 0.89 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9531889 0.88 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9531928 0.87 AGTR1 (0.34) AGTR1AGTR2
SCHEMBL9529899 0.85 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9529739 0.85 AGTR1 (0.35) AGTR1AGTR2
SCHEMBL9528318 0.85 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL8540070 0.85 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9529794 0.84 AGTR1 (0.36) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed